Signaling Pathways Intraepidermal Inflammation by Independent Induces Keratinocyte Apoptosis and a Activation of Cutaneous Protein Kinase C

Skin keratinocytes are major mediators of host immune responses. The skin is also a target for immunologically based inflammation in many pathological states. Activation of protein kinase C (PKC) can induce cutaneous inflammation, but the precise role of each of six cutaneous PKC isoforms ( (cid:1) , (cid:2) , (cid:3) , (cid:4) , (cid:5) , (cid:6) ) that regulate normal skin homeostasis or contribute to skin pathology has not been clarified. We generated transgenic mice that overexpress PKC (cid:1) in the basal layer of the epidermis and the outer root sheath of hair follicles under the regulation of the bovine keratin 5 promoter. K5-PKC (cid:1) transgenic mice exhibit severe intraepidermal neutrophilic inflammation and disruption of the epidermis and upper hair follicles when treated topically with 12- O -tetradecanoylphorbol-13-acetate (TPA). Both TPA and UVB cause apoptosis in transgenic skin, but only TPA evokes intraepidermal inflammation. TPA also induces apoptosis in cultured transgenic keratinocytes, and this is prevented by an AP-1 dominant-negative construct. However, inhibiting AP-1 in vivo does not abrogate intraepidermal inflammation. Transcripts for specific cytokines and chemokines are elevated in TPA-treated cultured transgenic keratinocytes, and conditioned culture medium from these cells promotes neutrophil migration in vitro. Chemokine expression and neutrophil migration are not diminished by inhibiting AP-1. Thus, PKC (cid:1) activation induces keratinocyte apoptosis via an AP-1-dependent pathway and mediates chemokine induction and intraepidermal inflammation independently. This model system will be useful to define specific chemokines regulated by PKC (cid:1) that promote intraepidermal neutrophilic inflammation, a condition that characterizes several human cutaneous diseases such as pustular psoriasis and acute generalized exanthem-atous pustulosis. The Journal of Immunology, 2003, 171: 2703–2713.

[1]  Wei Zhang,et al.  IL-12 completely blocks ultraviolet-induced secretion of tumor necrosis factor alpha from cultured skin fibroblasts and keratinocytes. , 2003, The Journal of investigative dermatology.

[2]  E. García-Ramallo,et al.  Resident Cell Chemokine Expression Serves as the Major Mechanism for Leukocyte Recruitment During Local Inflammation , 2002, The Journal of Immunology.

[3]  F. Marks,et al.  Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Courtois,et al.  TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2 , 2002, Nature.

[5]  Victor E. Marquez,et al.  Diacylglycerol (DAG)-lactones, a New Class of Protein Kinase C (PKC) Agonists, Induce Apoptosis in LNCaP Prostate Cancer Cells by Selective Activation of PKCα* , 2002, The Journal of Biological Chemistry.

[6]  M. Olive,et al.  Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines , 2002, Cancer Gene Therapy.

[7]  D. Wheeler,et al.  Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor–promotion susceptibilities of protein kinase Cα, ‐δ and ‐ϵ transgenic mice , 2001 .

[8]  R. Smart,et al.  Protein kinase C-alpha coordinately regulates cytosolic phospholipase A(2) activity and the expression of cyclooxygenase-2 through different mechanisms in mouse keratinocytes. , 2001, Molecular pharmacology.

[9]  Joseph D. Schwartzman,et al.  Mice Lacking the Chemokine Receptor CCR1 Show Increased Susceptibility to Toxoplasma gondii Infection1 , 2001, The Journal of Immunology.

[10]  C. Vinson,et al.  Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes. , 2000, Cancer research.

[11]  Jennifer A. Clark,et al.  Protein Kinase C Signaling Mediates a Program of Cell Cycle Withdrawal in the Intestinal Epithelium , 2000, The Journal of cell biology.

[12]  A. Glick,et al.  Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. , 2000, The Journal of investigative dermatology.

[13]  P. Stein,et al.  A PKC-eta/Fyn-dependent pathway leading to keratinocyte growth arrest and differentiation. , 2000, Molecular cell.

[14]  R. Paus,et al.  High‐dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo , 2000, The British journal of dermatology.

[15]  H. Rosenberg,et al.  The Chemokine Macrophage-Inflammatory Protein-1α and Its Receptor CCR1 Control Pulmonary Inflammation and Antiviral Host Defense in Paramyxovirus Infection , 2000, The Journal of Immunology.

[16]  C. Caux,et al.  Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis1 , 2000, The Journal of Immunology.

[17]  T. Ruzicka,et al.  Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice. , 2000, The Journal of investigative dermatology.

[18]  J. Zou,et al.  Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion. , 2000, Cancer research.

[19]  R. Eckert,et al.  Regulation of Human Involucrin Promoter Activity by Novel Protein Kinase C Isoforms* , 2000, The Journal of Biological Chemistry.

[20]  Luowei Li,et al.  Protein Kinase Cδ Targets Mitochondria, Alters Mitochondrial Membrane Potential, and Induces Apoptosis in Normal and Neoplastic Keratinocytes When Overexpressed by an Adenoviral Vector , 1999, Molecular and Cellular Biology.

[21]  I. Schieren,et al.  The α isoform of protein kinase C mediates phorbol ester-induced growth inhibition and p21cip1 induction in HC11 mammary epithelial cells , 1999, Oncogene.

[22]  C. Tseng,et al.  Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. , 1999, Cancer research.

[23]  R. Smart,et al.  Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion. , 1999, Journal of cell science.

[24]  M. Behrens,et al.  Prevention of neuronal apoptosis by phorbol ester-induced activation of protein kinase C: blockade of p38 mitogen-activated protein kinase , 1999, Neuroscience.

[25]  K. Imai,et al.  Protein kinase Cα promotes apoptotic cell death in gastric cancer cells depending upon loss of anchorage , 1999, Oncogene.

[26]  G. Dotto.  Signal transduction pathways controlling the switch between keratinocyte growth and differentiation. , 1999, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[27]  S. Rotenberg,et al.  Overexpression of protein kinase Calpha in MCF-10A human breast cells engenders dramatic alterations in morphology, proliferation, and motility. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[28]  B. Nickoloff,et al.  Protein Kinase Cδ Is Activated by Caspase-dependent Proteolysis during Ultraviolet Radiation-induced Apoptosis of Human Keratinocytes* , 1998, The Journal of Biological Chemistry.

[29]  W. May,et al.  A Functional Role for Mitochondrial Protein Kinase Cα in Bcl2 Phosphorylation and Suppression of Apoptosis* , 1998, The Journal of Biological Chemistry.

[30]  N. Huh,et al.  Induction of Differentiation in Normal Human Keratinocytes by Adenovirus-Mediated Introduction of the η and δ Isoforms of Protein Kinase C , 1998, Molecular and Cellular Biology.

[31]  A. Saran,et al.  Effect of genetic modification of acute inflammatory responsiveness on tumorigenesis in the mouse. , 1998, Carcinogenesis.

[32]  B. Spiegelman,et al.  Opposing activities of c-Fos and Fra-2 on AP-1 regulated transcriptional activity in mouse keratinocytes induced to differentiate by calcium and phorbol esters , 1997, Oncogene.

[33]  M. Olive,et al.  A Dominant Negative to Activation Protein-1 (AP1) That Abolishes DNA Binding and Inhibits Oncogenesis* , 1997, The Journal of Biological Chemistry.

[34]  H. Broxmeyer,et al.  Impaired Host Defense, Hematopoiesis, Granulomatous Inflammation and Type 1–Type 2 Cytokine Balance in Mice Lacking CC Chemokine Receptor 1 , 1997, The Journal of experimental medicine.

[35]  Yun‐Sil Lee,et al.  Definition by specific antisense oligonucleotides of a role for protein kinase Cα in expression of differentiation markers in normal and neoplastic mouse epidermal keratinocytes , 1997, Molecular carcinogenesis.

[36]  E. Bröcker,et al.  Differential Expression of GRO-α and IL-8 mRNA Psoriasis: A Model for Neutrophil Migration and Accumulation In Vivo , 1996 .

[37]  Koichiro Nakamura,et al.  Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease. , 1996, The Journal of clinical investigation.

[38]  B. Spiegelman,et al.  Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins. , 1996, Oncogene.

[39]  K. Valerie,et al.  Role of c-jun in human myeloid leukemia cell apoptosis induced by pharmacological inhibitors of protein kinase C. , 1996, Molecular pharmacology.

[40]  J. F. Klement,et al.  IkBa Deficiency Results in a Sustained NF-kB Response and Severe Widespread Dermatitis in Mice , 1996 .

[41]  R. Eckert,et al.  Differential expression of the fos and jun family members c-fos, fosB, Fra-1, Fra-2, c-jun, junB and junD during human epidermal keratinocyte differentiation. , 1995, Oncogene.

[42]  J. Kieffer,et al.  Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Olive,et al.  Extending dimerization interfaces: the bZIP basic region can form a coiled coil. , 1995, The EMBO journal.

[44]  A. Ullrich,et al.  Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. , 1995, The EMBO journal.

[45]  P. V. D. van de Kerkhof,et al.  Signal transduction pathways in epidermal proliferation and cutaneous inflammation. , 1995, Clinics in dermatology.

[46]  Z. Szallasi,et al.  Specific protein kinase C isozymes mediate the induction of keratinocyte differentiation markers by calcium. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[47]  S. Yuspa,et al.  Isolation and utilization of epidermal keratinocytes for oncogene research. , 1995, Methods in enzymology.

[48]  S. Yuspa,et al.  Alterations in murine keratinocyte differentiation induced by activated rasHa genes are mediated by protein kinase C-alpha. , 1994, Cancer research.

[49]  D. Carrasco,et al.  Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells , 1994, The Journal of experimental medicine.

[50]  M. Vidal,et al.  Sequences 5' of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. , 1994, Differentiation; research in biological diversity.

[51]  R. Flavell,et al.  AP‐1 transcriptional activity requires both T‐cell receptor‐mediated and co‐stimulatory signals in primary T lymphocytes. , 1994, The EMBO journal.

[52]  J. Jorcano,et al.  Analysis of the control of expression and tissue specificity of the keratin 5 gene, characteristic of basal keratinocytes. Fundamental role of an AP-1 element. , 1994, The Journal of biological chemistry.

[53]  T. Kuroki,et al.  Differentiation-associated localization of nPKC eta, a Ca(++)-independent protein kinase C, in normal human skin and skin diseases. , 1993, The Journal of investigative dermatology.

[54]  J. Celis,et al.  Evidence for an altered protein kinase C (PKC) signaling pathway in psoriasis. , 1993, The Journal of investigative dermatology.

[55]  James T. Elder,et al.  Differential Expression of Protein Kinase C Isoenzymes in Normal and Psoriatic Adult Human Skin: Reduced Expression of Protein Kinase C-βII in Psoriasis , 1993 .

[56]  S. Yuspa,et al.  Coordinate changes in gene expression which mark the spinous to granular cell transition in epidermis are regulated by protein kinase C , 1993, The Journal of cell biology.

[57]  K. Punnonen,et al.  Analysis of phospholipid metabolism in murine keratinocytes transformed by the v-ras oncogene: relationship of phosphatidylinositol turnover and cytokine stimulation to the transformed phenotype. , 1992, Carcinogenesis.

[58]  K. Turksen,et al.  Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice. , 1992, Genes & development.

[59]  J. Voorhees,et al.  Increased phospholipase C-catalyzed hydrolysis of phosphatidylinositol-4,5-bisphosphate and 1,2-sn-diacylglycerol content in psoriatic involved compared to uninvolved and normal epidermis. , 1990, The Journal of investigative dermatology.

[60]  T. Slaga,et al.  Cutaneous changes during prolonged application of 12-O-tetradecanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment. , 1985, Cancer research.